Skip to main content

Table 1 Baseline characteristics.

From: Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes

Sex (Male/Female)

8/12

Age (years)

61.2 ± 14.0

Duration of diabetes (years)

16.9 ± 6.6

HbA1c (%)

9.1 ± 1.2

Body mass index (kg/m2)

28.3 ± 5.2

Waist circumference (cm)

100.0 ± 11.8

Waist-to-hip ratio

1.01 ± 0.07

Estimated visceral fat area (cm2)

182.6 ± 68.3

LDL-C (mg/dL)

112.7 ± 29.1

HDL-C (mg/dL)

45.7 ± 8.8

Triglycerides (mg/dL)

141.6 ± 68.2

Uric acid (mg/dL)

6.0 ± 1.5

History of smoking (%)

30

Hypertension (%)

70

Dyslipidemia (%)

95

History of cardiovascular disease (%)

30

Medication for Diabetes

 

   Biguanide (%)

50

   Sulfonylurea (%)

45

   Alpha-glucosidase inhibitor (%)

30

   Thiazolidinedione (%)

25

   DPP-IV inhibitor (%)

10

   Glinide (%)

10

   Insulin (%)

65

  1. Data are mean ± SD or number of subjects. LDL-C; low-density lipoprotein-cholesterol, HDL-C; high-density lipoprotein-cholesterol, DPP-IV; dipeptidyl peptidase-IV.